-
Je něco špatně v tomto záznamu ?
Exosomal microRNAs and other non-coding RNAs as colorectal cancer biomarkers: a review
A. Francavilla, S. Turoczi, S. Tarallo, P. Vodicka, B. Pardini, A. Naccarati
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
Grantová podpora
NV15-27580A
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
NLK
Free Medical Journals
od 1996 do Před 1 rokem
Open Access Digital Library
od 1996-01-01
Medline Complete (EBSCOhost)
od 1996-01-01 do Před 1 rokem
PubMed
31784760
DOI
10.1093/mutage/gez038
Knihovny.cz E-zdroje
- MeSH
- exozómy genetika metabolismus MeSH
- extracelulární vezikuly genetika metabolismus MeSH
- kolorektální nádory krev diagnóza genetika metabolismus MeSH
- lidé MeSH
- mikro RNA genetika metabolismus MeSH
- nádorové biomarkery genetika metabolismus MeSH
- nekódující RNA genetika metabolismus MeSH
- progrese nemoci MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
The circulating human transcriptome, which includes both coding and non-coding RNA (ncRNA) molecules, represents a rich source of potential biomarkers for colorectal cancer (CRC) that has only recently been explored. In particular, the release of RNA-containing extracellular vesicles (EVs), in a multitude of different in vitro cell systems and in a variety of body fluids, has attracted wide interest. The role of RNA species in EVs is still not fully understood, but their capacity to act as a form of distant communication between cells and their higher abundance in association with cancer demonstrated their relevance. In this review, we report the evidence from both in vitro and human studies on microRNAs (miRNAs) and other ncRNA profiles analysed in EVs in relation to CRC as diagnostic, prognostic and predictive markers. The studies so far highlighted that, in exosomes, the most studied category of EVs, several miRNAs are able to accurately discriminate CRC cases from controls as well as to describe the progression of the disease and its prognosis. Most of the time, the in vitro findings support the miRNA profiles detected in human exosomes. The expression profiles measured in exosomes and other EVs differ and, interestingly, there is a variability of expression also among different subsets of exosomes according to their proteic profile. On the other hand, evidence is still limited for what concerns exosome miRNAs as early diagnostic and predictive markers of treatment. Several other ncRNAs that are carried by exosomes, mostly long ncRNAs and circular RNAs, seem also to be dysregulated in CRC. Besides various technical challenges, such as the standardisation of EVs isolation methods and the optimisation of methodologies to characterise the whole spectrum of RNA molecules in exosomes, further studies are needed in order to elucidate their relevance as CRC markers.
Department of Molecular Biology of Cancer Institute of Experimental Medicine Prague Czech Republic
Italian Institute for Genomic Medicine c o IRCCS Candiolo Candiolo Turin Italy
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21012370
- 003
- CZ-PrNML
- 005
- 20210507103736.0
- 007
- ta
- 008
- 210420s2020 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/mutage/gez038 $2 doi
- 035 __
- $a (PubMed)31784760
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Francavilla, Antonio $u Italian Institute for Genomic Medicine (IIGM), c/o IRCCS Candiolo, Candiolo, Turin, Italy
- 245 10
- $a Exosomal microRNAs and other non-coding RNAs as colorectal cancer biomarkers: a review / $c A. Francavilla, S. Turoczi, S. Tarallo, P. Vodicka, B. Pardini, A. Naccarati
- 520 9_
- $a The circulating human transcriptome, which includes both coding and non-coding RNA (ncRNA) molecules, represents a rich source of potential biomarkers for colorectal cancer (CRC) that has only recently been explored. In particular, the release of RNA-containing extracellular vesicles (EVs), in a multitude of different in vitro cell systems and in a variety of body fluids, has attracted wide interest. The role of RNA species in EVs is still not fully understood, but their capacity to act as a form of distant communication between cells and their higher abundance in association with cancer demonstrated their relevance. In this review, we report the evidence from both in vitro and human studies on microRNAs (miRNAs) and other ncRNA profiles analysed in EVs in relation to CRC as diagnostic, prognostic and predictive markers. The studies so far highlighted that, in exosomes, the most studied category of EVs, several miRNAs are able to accurately discriminate CRC cases from controls as well as to describe the progression of the disease and its prognosis. Most of the time, the in vitro findings support the miRNA profiles detected in human exosomes. The expression profiles measured in exosomes and other EVs differ and, interestingly, there is a variability of expression also among different subsets of exosomes according to their proteic profile. On the other hand, evidence is still limited for what concerns exosome miRNAs as early diagnostic and predictive markers of treatment. Several other ncRNAs that are carried by exosomes, mostly long ncRNAs and circular RNAs, seem also to be dysregulated in CRC. Besides various technical challenges, such as the standardisation of EVs isolation methods and the optimisation of methodologies to characterise the whole spectrum of RNA molecules in exosomes, further studies are needed in order to elucidate their relevance as CRC markers.
- 650 _2
- $a nádorové biomarkery $x genetika $x metabolismus $7 D014408
- 650 _2
- $a kolorektální nádory $x krev $x diagnóza $x genetika $x metabolismus $7 D015179
- 650 _2
- $a progrese nemoci $7 D018450
- 650 _2
- $a exozómy $x genetika $x metabolismus $7 D055354
- 650 _2
- $a extracelulární vezikuly $x genetika $x metabolismus $7 D000067128
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mikro RNA $x genetika $x metabolismus $7 D035683
- 650 _2
- $a nekódující RNA $x genetika $x metabolismus $7 D022661
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Turoczi, Szimonetta $u Italian Institute for Genomic Medicine (IIGM), c/o IRCCS Candiolo, Candiolo, Turin, Italy
- 700 1_
- $a Tarallo, Sonia $u Italian Institute for Genomic Medicine (IIGM), c/o IRCCS Candiolo, Candiolo, Turin, Italy
- 700 1_
- $a Vodicka, Pavel $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Pardini, Barbara $u Italian Institute for Genomic Medicine (IIGM), c/o IRCCS Candiolo, Candiolo, Turin, Italy
- 700 1_
- $a Naccarati, Alessio $u Italian Institute for Genomic Medicine (IIGM), c/o IRCCS Candiolo, Candiolo, Turin, Italy $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Prague, Czech Republic
- 773 0_
- $w MED00003429 $t Mutagenesis $x 1464-3804 $g Roč. 35, č. 3 (2020), s. 243-260
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31784760 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210420 $b ABA008
- 991 __
- $a 20210507103735 $b ABA008
- 999 __
- $a ok $b bmc $g 1650692 $s 1132749
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 35 $c 3 $d 243-260 $e 20200711 $i 1464-3804 $m Mutagenesis $n Mutagenesis $x MED00003429
- GRA __
- $a NV15-27580A $p MZ0
- LZP __
- $a Pubmed-20210420